跳至主要内容
临床试验/EUCTR2019-000742-35-IT
EUCTR2019-000742-35-IT进行中(未招募)1 期

PROTOCOL FOR THE DIAGNOSIS AND THERAPY OF INTRAOCULAR RETINOBLASTOMA - RTB AIEOP 018

ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA0 个研究点目标入组 44 人开始时间: 2021年5月24日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Clinical diagnosis of single or bilateral intraocular Retinoblastoma (stage 0 according to International Retinoblastoma Staging System-IRSS)
  • Patients <16 years old
  • No previous chemo or radiotherapy treatment
  • . Ophthalmological evaluation with Fundus Cam Overview and classification of intraocular lesions according to International Intraocular Retinolastoma Classification-IIRC - Performance status: Lansky = 50
  • Written informed consent signed by parents or legal guardian
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients = 16 years old
  • Patients not evaluated with panormic Fundus-Cam at diagnosis
  • Patients who have received prior chemo or radiotherapy treatments
  • Ongoing pregnancy or breastfeeding
  • Hypersensitivity to any component of the study drugs
  • Vaccination with live and attenuated virus
  • Subjects with neuromuscular disorders
  • Presence of exclusion criteria for conservative treatment
  • Absence of eligibility criteria for the study

研究者

发起方
ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA

相似试验